- Report
- January 2026
- 160 Pages
Global
From €2832EUR$3,160USD£2,430GBP
€3540EUR$3,950USD£3,037GBP
- Report
- January 2026
- 160 Pages
Global
From €2832EUR$3,160USD£2,430GBP
€3540EUR$3,950USD£3,037GBP
- Report
- January 2026
- 160 Pages
Global
From €2832EUR$3,160USD£2,430GBP
€3540EUR$3,950USD£3,037GBP
- Report
- July 2026
- 135 Pages
Global
From €4347EUR$4,850USD£3,729GBP
- Report
- May 2026
- 146 Pages
Global
From €3540EUR$3,950USD£3,037GBP
- Report
- May 2026
- 145 Pages
Global
From €3540EUR$3,950USD£3,037GBP
- Report
- May 2026
- 165 Pages
Global
From €3540EUR$3,950USD£3,037GBP
- Report
- May 2026
- 152 Pages
Global
From €3540EUR$3,950USD£3,037GBP
- Report
- May 2026
- 154 Pages
Global
From €3540EUR$3,950USD£3,037GBP
- Report
- May 2026
- 151 Pages
Global
From €3540EUR$3,950USD£3,037GBP
- Report
- May 2026
- 146 Pages
Global
From €3540EUR$3,950USD£3,037GBP
- Report
- November 2025
- 147 Pages
Global
From €3540EUR$3,950USD£3,037GBP
- Report
- August 2025
- 149 Pages
Global
From €3540EUR$3,950USD£3,037GBP
- Report
- February 2026
- 179 Pages
Global
From €4347EUR$4,850USD£3,729GBP
- Report
- February 2026
- 178 Pages
Global
From €4347EUR$4,850USD£3,729GBP
- Report
- February 2026
- 150 Pages
Global
From €4347EUR$4,850USD£3,729GBP
- Report
- February 2026
- 191 Pages
Global
From €4347EUR$4,850USD£3,729GBP
- Report
- February 2026
- 203 Pages
Global
From €4347EUR$4,850USD£3,729GBP
- Report
- February 2026
- 164 Pages
Global
From €4347EUR$4,850USD£3,729GBP
- Report
- February 2026
- 186 Pages
Global
From €4347EUR$4,850USD£3,729GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more